These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 27866991)

  • 1. Parkinson's disease-like motor and non-motor symptoms in rotenone-treated zebrafish.
    Wang Y; Liu W; Yang J; Wang F; Sima Y; Zhong ZM; Wang H; Hu LF; Liu CF
    Neurotoxicology; 2017 Jan; 58():103-109. PubMed ID: 27866991
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sleep deprivation caused a memory defects and emotional changes in a rotenone-based zebrafish model of Parkinson's disease.
    Lv DJ; Li LX; Chen J; Wei SZ; Wang F; Hu H; Xie AM; Liu CF
    Behav Brain Res; 2019 Oct; 372():112031. PubMed ID: 31195038
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rotenone induces gastrointestinal pathology and microbiota alterations in a rat model of Parkinson's disease.
    Johnson ME; Stringer A; Bobrovskaya L
    Neurotoxicology; 2018 Mar; 65():174-185. PubMed ID: 29471018
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antiparkinson potential of khellin on rotenone-induced Parkinson's disease in a zebrafish model: targeting MAO, inflammatory, and oxidative stress markers with molecular docking, MD simulations, and histopathology evidence.
    Hemanth Babu A; Prasanth DSNBK; Yaraguppi DA; Panda SP; Ahmad SF; Al-Mazroua HA; Sai AR; Praveen Kumar P
    Comp Biochem Physiol C Toxicol Pharmacol; 2024 Oct; 284():109997. PubMed ID: 39103133
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ameliorative effect of Sida cordifolia in rotenone induced oxidative stress model of Parkinson's disease.
    Khurana N; Gajbhiye A
    Neurotoxicology; 2013 Dec; 39():57-64. PubMed ID: 23994302
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessment of gait dynamics in rotenone-induced rat model of Parkinson's disease by footprint method.
    Madiha S; Tabassum S; Batool Z; Liaquat L; Sadir S; Shahzad S; Perveen T; Haider S
    Pak J Pharm Sci; 2017 May; 30(3(Suppl.)):943-948. PubMed ID: 28655689
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diet with Low Molecular Weight Chitosan exerts neuromodulation in Rotenone induced Drosophila model of Parkinson's disease.
    Pramod Kumar P; Harish Prashanth KV
    Food Chem Toxicol; 2020 Dec; 146():111860. PubMed ID: 33212211
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Depressive-like behaviors alterations induced by intranigral MPTP, 6-OHDA, LPS and rotenone models of Parkinson's disease are predominantly associated with serotonin and dopamine.
    Santiago RM; Barbieiro J; Lima MM; Dombrowski PA; Andreatini R; Vital MA
    Prog Neuropsychopharmacol Biol Psychiatry; 2010 Aug; 34(6):1104-14. PubMed ID: 20547199
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The behavioural and neuropathological impact of intranigral AAV-α-synuclein is exacerbated by systemic infusion of the Parkinson's disease-associated pesticide, rotenone, in rats.
    Mulcahy P; O'Doherty A; Paucard A; O'Brien T; Kirik D; Dowd E
    Behav Brain Res; 2013 Apr; 243():6-15. PubMed ID: 23295396
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sensitivity of zebrafish to environmental toxins implicated in Parkinson's disease.
    Bretaud S; Lee S; Guo S
    Neurotoxicol Teratol; 2004; 26(6):857-64. PubMed ID: 15451049
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quercetin exhibits potent antioxidant activity, restores motor and non-motor deficits induced by rotenone toxicity.
    Madiha S; Batool Z; Tabassum S; Liaquat L; Sadir S; Shahzad S; Naqvi F; Saleem S; Yousuf S; Nawaz A; Ahmad S; Sajid I; Afzal A; Haider S
    PLoS One; 2021; 16(11):e0258928. PubMed ID: 34767546
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An update on the rotenone models of Parkinson's disease: their ability to reproduce the features of clinical disease and model gene-environment interactions.
    Johnson ME; Bobrovskaya L
    Neurotoxicology; 2015 Jan; 46():101-16. PubMed ID: 25514659
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of acetic acid-induced pain in Parkinson's disease model in zebrafish.
    Cansiz D; Unal I; Beler M; Ustundag UV; Ak E; Emekli-Alturfan E; Alturfan AA
    Neurotoxicology; 2023 Dec; 99():14-23. PubMed ID: 37683694
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Microarray-based Analysis of Differential Gene Expression Profile in Rotenone-induced Parkinson's Disease Zebrafish Model.
    Nies YH; Yahaya MF; Lim WL; Teoh SL
    CNS Neurol Disord Drug Targets; 2024; 23(6):761-772. PubMed ID: 37291778
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential pattern of motor impairments in neurotoxic, environmental and inflammation-driven rat models of Parkinson's disease.
    Naughton C; Moriarty N; Feehan J; O'Toole D; Dowd E
    Behav Brain Res; 2016 Jan; 296():451-458. PubMed ID: 26393432
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sesamol and naringenin reverse the effect of rotenone-induced PD rat model.
    Sonia Angeline M; Sarkar A; Anand K; Ambasta RK; Kumar P
    Neuroscience; 2013 Dec; 254():379-94. PubMed ID: 24070629
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Delayed gastric emptying and enteric nervous system dysfunction in the rotenone model of Parkinson's disease.
    Greene JG; Noorian AR; Srinivasan S
    Exp Neurol; 2009 Jul; 218(1):154-61. PubMed ID: 19409896
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of pioglitazone and retinoic acid in a rotenone model of Parkinson's disease.
    Ulusoy GK; Celik T; Kayir H; Gürsoy M; Isik AT; Uzbay TI
    Brain Res Bull; 2011 Jul; 85(6):380-4. PubMed ID: 21600965
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Trehalose ameliorates prodromal non-motor deficits and aberrant protein accumulation in a rotenone-induced mouse model of Parkinson's disease.
    Moon SH; Kwon Y; Huh YE; Choi HJ
    Arch Pharm Res; 2022 Jun; 45(6):417-432. PubMed ID: 35618982
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neuroprotection by valproic acid in an intrastriatal rotenone model of Parkinson's disease.
    Carriere CH; Kang NH; Niles LP
    Neuroscience; 2014 May; 267():114-21. PubMed ID: 24613722
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.